Labyrinthitis

Jump to navigation Jump to search
Labyrinthitis
ICD-10 H83.0
ICD-9 386.3
DiseasesDB 29290
MeSH C09.218.568.315

WikiDoc Resources for Labyrinthitis

Articles

Most recent articles on Labyrinthitis

Most cited articles on Labyrinthitis

Review articles on Labyrinthitis

Articles on Labyrinthitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Labyrinthitis

Images of Labyrinthitis

Photos of Labyrinthitis

Podcasts & MP3s on Labyrinthitis

Videos on Labyrinthitis

Evidence Based Medicine

Cochrane Collaboration on Labyrinthitis

Bandolier on Labyrinthitis

TRIP on Labyrinthitis

Clinical Trials

Ongoing Trials on Labyrinthitis at Clinical Trials.gov

Trial results on Labyrinthitis

Clinical Trials on Labyrinthitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Labyrinthitis

NICE Guidance on Labyrinthitis

NHS PRODIGY Guidance

FDA on Labyrinthitis

CDC on Labyrinthitis

Books

Books on Labyrinthitis

News

Labyrinthitis in the news

Be alerted to news on Labyrinthitis

News trends on Labyrinthitis

Commentary

Blogs on Labyrinthitis

Definitions

Definitions of Labyrinthitis

Patient Resources / Community

Patient resources on Labyrinthitis

Discussion groups on Labyrinthitis

Patient Handouts on Labyrinthitis

Directions to Hospitals Treating Labyrinthitis

Risk calculators and risk factors for Labyrinthitis

Healthcare Provider Resources

Symptoms of Labyrinthitis

Causes & Risk Factors for Labyrinthitis

Diagnostic studies for Labyrinthitis

Treatment of Labyrinthitis

Continuing Medical Education (CME)

CME Programs on Labyrinthitis

International

Labyrinthitis en Espanol

Labyrinthitis en Francais

Business

Labyrinthitis in the Marketplace

Patents on Labyrinthitis

Experimental / Informatics

List of terms related to Labyrinthitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Aditya Ganti M.B.B.S. [2]

Synonyms and keywords: Otitis interna, vestibular neuronitis, vestibular neuritis


Overview

Historical Perspective

Classification

Based on radiological findings, labyrinthitis can be classified into 3 types[1]

  • CLA with hypoplastic or aplastic petrous bone[2]
  • CLA without otic capsule
  • CLA with otic capsule

Pathophysiology

Causes

Differentiating Xyz from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis


Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention


Overview

Labyrinthitis is a balance disorder. It is an inflammatory process affecting the labyrinths that house the vestibular system (which sense changes in head position) of the inner ear.

In addition to balance control problems, a labyrinthitis patient may encounter hearing loss and tinnitus. Labyrinthitis is caused by a virus, but it can also arise from bacterial infection, head injury, an allergy or as a reaction to a particular medicine. Both bacterial and viral labyrinthitis can cause permanent hearing loss, although this is rare.

Labyrinthitis often follows an upper respiratory tract infection (URI).

Labyrinthitis and vertigo

A prominent and debilitating symptom of labyrinthitis is chronic dizziness. The vestibular system is a of sensory inputs consisting of three semicircular canals, sensing changes in rotational motion, and the otoliths, sensing changes in linear motion. The brain combines visual cues with sensory input from the vestibular system to determine adjustments required to retain balance. When working properly, the vestibular system also relays information on head movement to the eye muscle, forming the vestibulo-ocular reflex, in order to retain continuous visual focus during motion. When the vestibular system is affected by labyrinthitis, rapid, undesired eye motion (nystagmus), often results from the improper indictations of rotational motion. Nausea, anxiety, and a general ill feeling are common due to the distorted balance signals that the brain receives from the inner ear.

Recovery

Recovery from acute labyrinthine inflammation generally takes from one to six weeks; however, it is not uncommon for residual symptoms (dysequilibrium and/or dizziness) to last for many months or even years (Bronstein, 2002) if permanent damage occurs.

Recovery from a permanently damaged inner ear typically follows three phases:

  1. An acute period, which may include severe vertigo and vomiting
  2. approximately two weeks of subacute symptoms and rapid recovery
  3. finally a period of chronic compensation which may last for months or years.

Labyrinthitis and anxiety

Chronic anxiety is a common side effect of labyrinthitis which can produce tremors, heart palpitations, panic attacks and depression. Often a panic attack is one of the first symptoms to occur as labyrinthitis begins. While dizziness can occur from extreme anxiety, labyrinthitis itself can precipitate a panic disorder. Three models have been proposed to explain the relationship between vestibular dysfunction and panic disorder (Simon et al., 1998):

  • Psychosomatic model: vestibular dysfunction which occurs as a result of anxiety.
  • Somatopsychic model: panic disorder triggered by misinterpreted internal stimuli (e.g., stimuli from vestibular dysfunction), that are interpreted as signifying imminent physical danger. Heightened sensitivity to vestibular sensations leads to increased anxiety and, through conditioning, drives the development of panic disorder.
  • Network alarm theory: panic which involves noradrenergic, serotonergic, and other connected neuronal systems. According to this theory, panic can be triggered by stimuli that set off a false alarm via afferents to the locus ceruleus, which then triggers the neuronal network. This network is thought to mediate anxiety and includes limbic, midbrain and prefrontal areas. Vestibular dysfunction in the setting of increased locus ceruleus sensitivity may be a potential trigger.

Treatment

Prochlorperazine is commonly prescribed to help alleviate the symptoms of vertigo and nausea.

Because anxiety interferes with the balance compensation process, it is important to treat an anxiety disorder and/or depression as soon as possible to allow the brain to compensate for any vestibular damage. Acute anxiety can be treated in the short term with benzodiazepines such as diazepam (Valium); however, long-term use is not recommended because of the addictive nature of benzodiazepines and the interference they may cause with vestibular compensation and adaptive plasticity (Solomon and Shepard, 2002).

Evidence suggests that selective serotonin-reuptake inhibitors may be more effective in treating labyrinthitis. They act by relieving anxiety symptoms and may stimulate new neural growth within the inner ear, allowing more rapid vestibular compensation to occur. Trials have shown that SSRIs do in fact affect the vestibular system in a direct manner and can decrease dizziness (Staab and Ruckenstein, 2005).

Some evidence suggests that viral labyrinthitis should be treated in its early stages with corticosteroids such as prednisone, and possibly antiviral medication such as Valtrex and that this treatment should be undertaken as soon as possible to prevent permanent damage to the inner ear.

Vestibular rehabilitation therapy (VRT) is a highly effective way to substantially reduce or eliminate residual dizziness from labyrinthitis. VRT works by causing the brain to use already existing neural mechanisms for adaptation, plasticity, and compensation. The direction, duration, frequency, and magnitude of the directed exercises are closely correlated with adaptation and recovery. Symmetry is more rapidly restored when VRT exercises are specifically tailored for the patient.

In one study, Bronstein (2002) found that patients who believed their illness was out of their control showed the slowest progression to full recovery, long after the initial vestibular injury had healed. The study revealed that the patient who compensated well was one who, at the psychological level, was not afraid of the symptoms and had some positive control over them. Notably, a reduction in negative beliefs over time was greater in those patients treated with rehabilitation than in those untreated. "Of utmost importance, baseline beliefs were the only significant predictor of change in handicap at 6 months followup."

Chinese herbal medicine and/or acupuncture may help reduce symptoms; however, there currently is no hard evidence to support this.

See also

References

  • Bronstein A (2002), Visual and psychological aspects of vestibular disease, Current Opinion in Neurology 2002, 15:1–3.
  • Simon NM, Pollack MH, Tuby KS et al (1998), Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety, Ann Clin Psychiatry, 10(2):75–80.
  • Solomon D and Shepard NT (2002), Chronic Dizziness, Current Treatment Options in Neurology, 4:281–288.
  • Staab J and Ruckenstein M (2005), Chronic Dizziness and Anxiety, Arch Otolaryngol Head Neck Surg, 131:675-679.

External links


Template:Diseases of the ear and mastoid process hr:Labirintitis it:Labirintite nl:Labyrintitis

Template:WH Template:WikiDoc Sources

  1. Olshansky, Brian (2004). "Combining ablation of atrial fibrillation with ablation of atrial flutter: are we there yet?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology". Journal of the American College of Cardiology. 43 (11): 2063–2065. doi:10.1016/j.jacc.2004.03.020. ISSN 0735-1097.
  2. Olshansky, Brian (2004). "Combining ablation of atrial fibrillation with ablation of atrial flutter: are we there yet?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology". Journal of the American College of Cardiology. 43 (11): 2063–2065. doi:10.1016/j.jacc.2004.03.020. ISSN 0735-1097.